{"id":183237,"name":"TONIX PHARMACEUTICALS, INC.","slug":"tonix-pharmaceuticals-inc","state":"NJ","country":"United States of America","description":"biotechnology company--pharmaceuticals development and manufacturing","totalSpending":650000,"filings":30,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":80000},{"year":2020,"income":70000},{"year":2021,"income":60000},{"year":2022,"income":120000},{"year":2023,"income":120000},{"year":2024,"income":120000},{"year":2025,"income":40000}],"issues":[{"code":"VET","display":"Veterans"},{"code":"DEF","display":"Defense"},{"code":"HCR","display":"Health Issues"},{"code":"DIS","display":"Disaster Planning/Emergencies"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["CARDINAL POINT PARTNERS"],"lobbyists":["STEVEN WOLFE"],"govEntities":["Army, Dept of (Other)","Defense, Dept of (DOD)","HOUSE OF REPRESENTATIVES","SENATE","Veterans Affairs, Dept of (VA)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Department of Veterans Affairs research and development on neuropsychiatric drug treatments","Medical research and development activities, including drug development, of the Department of Defense, including in the Defense Appropriations Act for FY2019","Medical research and development activities, including drug development, of the Department of Defense, including in the Defense Appropriations Act for FY2019 (S 3159) and the National Defense Authoriz","Department of Veterans Affairs research and development on neuropsychiatric drug treatments","Medical research and development activities, including drug development, of the Department of Defense"]}